Conference Abstracts - The 8th International Cancer Congress
Vol. 6, Issue Supplement 2, 2026 · S1-1
BRCA1-Positive Triple-Negative Breast Cancer: Risk-Reducing Bilateral Salpingo-Oophorectomy - A Hereditary Cancer Management Case
Sachin Chaudhary, MBBS, MD,Ankita Singh, MBBS, MD,Sunil Chumber, MBBS, MD,Piyush Ranjan, MBBS, MD,Reva Shankar Sahu, MBBS, MD,Parul Kadian, MBBS, MD
Submission received: 2026-08-27 / Accepted: 2026-08-30 / Published: 2026-09-24
Abstract
Background
BRCA1 mutations confer significantly elevated lifetime risks for breast and ovarian cancers. Triple-negative breast cancer (TNBC) disproportionately occurs in BRCA1-positive women. Risk-reducing bilateral salpingo-oophorectomy (RRSO) is recommended to reduce ovarian cancer incidence, though optimal timing and approach remain evolving in clinical practice.
Methods
A 58-year-old BRCA1-positive (heterozygous) woman presented with triple-negative breast cancer (following prior left mastectomy in 2002 and right wide local excision in 2011). She was counseled regarding hereditary cancer management and underwent laparoscopic bilateral risk-reducing salpingo-oophorectomy. Intraoperative findings were of normal bilateral ovaries and fallopian tubes with minimal adhesions (left fimbrial adhesion to sigmoid mesocolon). Peritoneal washings for cytology were obtained. Laparoscopically, bilateral salpingo-oophorectomy en bloc was done with adequate hemostasis. Postoperative course was uneventful and patient was discharged on POD1.
Conclusion
This case illustrates the practical application of prophylactic risk-reducing surgery in BRCA1-positive women with TNBC. Laparoscopic RRSO provides oncological benefits with minimal morbidity. The modern management of hereditary cancer, which includes the integration of genetic testing, multidisciplinary counseling, and prophylactic surgery, has the potential to reduce cancer disparities in at-risk populations.
